Partner Headlines - BCRX

  1. Momentum Stocks Showing Weakness

    Benzinga
  2. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  3. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  4. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  5. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  6. Biotechs That Might Benefit From Ebola

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Stocks Hitting 52-Week Highs

    Benzinga
  9. Benzinga's Top Initiations

    Benzinga
  10. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  11. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  12. Ebola Stocks Continue Higher

    Benzinga
  13. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  14. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  15. Benzinga's Top Initiations

    Benzinga
  16. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  17. Benzinga's Top #PreMarket Gainers

    Benzinga
  18. Benzinga's Top Downgrades

    Benzinga
  19. Benzinga's Top Initiations

    Benzinga
  20. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  21. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  22. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  23. Benzinga's Top #PreMarket Gainers

    Benzinga
  24. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  25. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  26. Benzinga's Top Pre-Market Gainers

    Benzinga
  27. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  28. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  29. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  30. Benzinga's Top Pre-Market Gainers

    Benzinga
  31. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  32. Benzinga's Top Pre-Market Gainers

    Benzinga
  33. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  34. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  35. Benzinga's Top Pre-Market Losers

    Benzinga
  36. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  37. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  38. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  39. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  40. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  41. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  42. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  43. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  44. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  45. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  46. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  47. A Peek Into The Market Before The Trading Starts

    Benzinga
  48. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  49. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  50. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  51. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  52. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  53. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  54. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  55. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  56. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center